
Hope for Britain's ash trees as study finds resistance evolving to killer fungus
Researchers from the Royal Botanic Gardens, Kew, and Queen Mary University of London say they have discovered a new generation of young ash trees in the wild which are showing greater resistance to the fungus compared to older trees.
The findings from the study focused on Marden Park wood in Surrey, a semi-natural ancient woodland dominated by ash, which is a species that produces a large number of seedlings from each adult.
It could mean ash does not go the same way as elms, which have been largely lost from the British landscape as a result of Dutch elm disease, the scientists said – although breeding programmes may be needed to bolster the fightback.
Ash dieback, which was first seen in the UK in 2012, causes leaf loss and crown dieback and can lead to tree death, with fears it could wipe out up to 85% of Britain's native ash trees, as they have not evolved natural defences against the fungus originally from Asia.
But now researchers suggest that natural selection in the wild is taking place on thousands of locations within ash tree DNA, driving increased resistance to the disease.
The study compared the DNA of ash trees established before and after the fungus arrived in Britain, and found shifts in variants associated with tree health in thousands of places across the overall genome of the trees.
This indicates the younger generation of trees has greater resistance to the fungus – as well as showing natural selection for a trait being influenced by multiple genes, which the researchers said was a phenomenon that was widely assumed but difficult to prove.
Their study in the journal Science said natural selection could be occurring partly due to reduced seed or pollen production by adult trees damaged by ash dieback, and partly through the rapid death of young trees infected by the fungus and so are not present in the wood.
But they cautioned that it was not yet known whether the rate of change would be enough to rescue the plants naturally, or whether there was enough genetic variation in ash trees to lead to a fully resistant tree.
The findings could be used to support breeding programmes that aim to make European ash trees resilient to the disease, they added.
Study author Dr Carey Metheringham, from Kew and Queen Mary, said: 'Thanks to natural selection, future generations of ash should have a better chance of withstanding infection.
'However, natural selection alone may not be enough to produce fully resistant trees.
'The existing genetic variation in the ash population may be too low, and as the trees become scarcer, the rate of selection could slow.
'Human intervention, such as selective breeding and the protection of young trees from deer grazing, may be required to accelerate evolutionary change.'
Another of the study's authors, Professor Richard Buggs, from Kew and Queen Mary, said: 'We are so glad that these findings suggest that ash will not go the way of the elm in Britain.
'Elm trees have struggled to evolve to Dutch elm disease, but ash are showing a very different dynamic because they produce an abundance of seedlings upon which natural selection can act when they are still young.
'Through the death of millions of ash trees, a more resistant population of ash is appearing.'
Rebecca Gosling, from the Woodland Trust which owns and manages Marden Park wood, said: 'Ash dieback demonstrates how devastating introduced pathogens can be for our trees and the species which rely upon them.
'This important research gives us hope for the future of our ash populations.'
She added: 'The findings highlight how vital it is to support natural regeneration in woodlands, furthering our understanding of how to best manage our ash woodlands.'
The study was mainly funded by the Environment Department (Defra) whose chief plant health officer Professor Nicola Spence said it demonstrated that tolerance to ash dieback can be inherited, and breeding programmes and natural regeneration together could secure the future of native ash.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
13 minutes ago
- Reuters
US Senator investigates GSK for pulling children's asthma inhaler
WASHINGTON, June 27 (Reuters) - Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's (GSK.L), opens new tab decision to discontinue a widely used asthma inhaler for children. In letters sent on Friday to GSK and its authorized generic distributor, Prasco Laboratories, and seen by Reuters, Hassan said the decision to remove Flovent HFA from the market in January 2024 had contributed to a spike in hospitalizations and deaths linked to asthma complications. She demanded documents detailing the rationale behind the decision, and its financial and health impacts. Hassan, the top Democrat on the Senate Finance Committee's Health Care Subcommittee, called on GSK to restore the inhaler to market. She also requested internal pricing documents, rebate data, and communications with regulators by July 18. She accused GSK of evading rebate obligations to Medicaid, which provides health coverage to 71 million low-income people and is one of the biggest U.S. safety-net programs. In addition, GSK's decision to replace the brand-name inhaler with a higher-cost authorized generic had lowered access for low-income patients, Hassan said. "Children across the country have faced life-threatening medical challenges and families have grappled with more expensive or less effective alternative medications — when these options are available at all," Hassan wrote in her letter. GSK told Hassan in response to an earlier letter she sent in May last year that Prasco controls pricing of the generic. Hassan said both companies failed to ensure affordability of the treatment, contributing to delays or denials of insurance coverage. Hassan cited a Johns Hopkins analysis which found that GSK's move saved the company $367 million in 2024 Medicaid rebates, while costing the program over $550 million. Parents reported paying up to $150 per inhaler for the generic, compared to $10 for Flovent. GSK said last year it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month for eligible patients in the United States starting January 2025, following similar moves by its rivals. The announcement came after lawmakers criticized manufacturers over high prices, and launched an investigation, opens new tab to look into the prices at which these were sold in the U.S. versus other countries.


Scottish Sun
3 hours ago
- Scottish Sun
Deadly brain-eating parasite is found in ‘contaminated' salad bags sold in UK supermarkets – 7 symptoms to watch out for
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) HEALTH warnings have been issued over salad bags due to potentially deadly contamination fears. The popular ready-to-eat product sold across UK supermarkets has been associated with a rise in food poisoning cases. Sign up for Scottish Sun newsletter Sign up 1 UK shoppers could be at risk of a brain-eating parasite found in some ready-to-eat salad bags (stock image) Credit: EPA Research carried out by the journal Eurosurveillance highlighted the contamination fears reported across 10 European countries, including the UK. This came after over 4% of the leaves in salad samples, tested between October 2021 and September 2022, were found to be contaminated with toxoplasma gondii oocysts. "The parasite Toxoplasma gondii can cause severe disease in humans," the research said. "People can acquire the parasite by eating raw or undercooked infected meat or unwashed fruits or vegetables contaminated with the parasite. "We wanted to investigate T. gondii in commercial ready-to eat (RTE) salads in European countries to estimate the importance of these food products as sources of T. gondii." The bacteria, which can be passed on through contact with cat faeces, has been known to contaminate food and water. This makes salad that is washed or watered with dirty water a prime place for bacteria to grow. According to research cited by Science Alert, this bacteria "can seriously disrupt the brain function of intermediate hosts, potentially including humans". The National Institute of Health previously reported that half of the UK population show signs of past infection by the age of 50. They added that once acquired, these parasites remain in human tissues for life. 'Contaminated' children's cough syrup recalled nationwide over ingredient inside that could kill – parents must act now Health risks This can cause a problem later in life for people who have a weakened immune system, often a result cancer treatments or immunosuppressant drugs. The Food Standards Agency recommended the best action to take to combat this outbreak. "[Always] wash fruit and vegetables with water before you eat them to make sure that they are clean," the experts advised. "You should wash them under a running tap, or in a bowl of fresh water, making sure to rub their skin under the water." While toxoplasmosis is not usually serious and normally gets better on its own, the NHS highlighted that it can cause serious problems in certain situations. Symptoms of toxoplasmosis According to the NHS, toxoplasmosis does not usually cause symptoms and often goes undetected. However, it can also result in flu-like symptoms such as: High temperature Headache Sore throat Aching body Swollen glands Feeling tired Feeling sick or being sick More serious symptoms can include: Confusion Blurred vision Slurred speech Unsteady walking This includes if you get it while you're pregnant or have a weakened immune system . If you have a weakened immune system toxoplasmosis may cause problems with your eyes, brain, heart, or lungs. And if you experience more severe symptoms such as confusion, blurred vision, or slurred speech, you should also seek medical help. Positive samples across Europe Samples of the leaves were collected in the Czech Republic, Denmark, France, Germany, Italy, Norway, Poland, Portugal, and Spain as well as the UK. Majority of the positive samples were collected in winter and packaged in the UK, France, Portugal, Spain, and Denmark. Scientists have urged for better control measures to help protect prevent infection. "This is particularly relevant since ready-to-eat salads are intended to be consumed raw without any further treatment by the consumer," they pointed out. "Future work should investigate presence of [the parasite] in different steps of the ready-to-eat production to minimise infection risk for humans." Rise in food poisoning cases The warning follows alerts relating to a significant rise in serious food poisoning cases. Health watchdogs reported a spike in Campylobacter and Salmonella infections across England compared to previous years. The latest annual data from the UK Health Security Agency (UKHSA) showed that Campylobacter infections increased by 17% between 2023 and 2014 - from 60,055 to 70,352. According to UKHSA, this represents the highest number of cases recorded in the past decade. Meanwhile, Salmonella infections also reached a decade high, according to data. They rose by with a 17% as well, from 8,872 cases in 2023 to 10,388 cases in 2024.


ITV News
3 hours ago
- ITV News
Jersey to make final decision on assisted dying law in December
Jersey will decide whether to officially legalise assisted dying later this year. The draft law will be published in early September before going through 14 weeks of political scrutiny, with a final debate and vote on Tuesday 9 December. If it passes, the legislation is expected to come into force in 2027. Health Minister, Deputy Tom Binet, says: "I think we're probably running a bit ahead of the game and I've been very impressed throughout with the people that have been doing this. "This could serve as a template for other places, it's that good." Politicians in Westminster recently passed the next stage of their assisted dying bill covering England and Wales. British MP Sarah Champion has been in Jersey to meet States Members and see how they can support one another. She explains: "It's looking to see where our systems are similar, where we can learn from each other and share experiences, good and bad, so we don't make the same mistakes." Jersey politicians backed the law change to allow assisted dying in principle by 32 votes to 14 in May 2024. It would see those aged 18 or over and living on the island for at least a year given the choice to end their life with the help of medical professionals if they have a terminal illness and less than six months to live, or 12 months if they have a neurodegenerative condition. Fran Hall from the campaign group Dignity in Dying says: "Momentum for change across the British Isles and beyond is unstoppable and we're really grateful that Jersey is leading this." Safeguards have been a key part of discussions about assisted dying legislation across the British Isles, due to concerns that vulnerable people could be coerced to end their lives. To combat this, the UK and the Isle of Man will bring in a specific 'coercion' offence punishable by up to 14 years in prison. Jersey has not yet defined this but ITV News understands coercion would likely fall under the island's existing homicide law, rather than being dealt with separately. This is an incredibly complicated issue and Jersey's Health Minister wants the States to have no excuse to say no when the assisted dying draft law is debated in December. The difference between Jersey and the UK is that in Westminster, their law is being proposed by a single MP, Kim Leadbeater, through a Private Members' Bill. Whereas, Jersey's legislation is being put forward by the island's government, making it more likely to be approved as they have a majority in the States Assembly. However, this is still an incredibly divisive topic and that is why Jersey politicians are so keen to talk about safeguarding with other jurisdictions. For example, compared to the Isle of Man, Jersey has different residency requirements, meaning someone could live in Jersey for a shorter amount of time before being eligible for an assisted death. What will be interesting is how Guernsey reacts with a new set of politicians - could they soon be the next place in the British Isles to propose assisted dying legislation? Some, like Gavin St Pier, believe it is time for the States to reconsider their position and follow Jersey's model.